한글목차

세계의 암 진단 시장은 2018년에 167억 7,881만 달러로 평가되며, 2023년까지 CAGR 4.0% 이상으로 성장했습니다.

맞춤형 의료에 대한 수요의 증가

맞춤형 의료에 대한 수요의 증가는 암 진단 시장의 성장을 촉진했습니다. 맞춤형 의료는 정밀의료 또는 개인맞춤의료라고도 불리며, 환자 개개인의 특성에 맞는 치료와 개입을 목표로 하는 의료 접근법입니다. 맞춤의료는 게놈 프로파일링, 표적치료, 예측 바이오마커, 정밀영상진단, 임상적 판단 지원, 의약품 개발의 혁신을 활용하여 암 진단을 강화합니다. 예를 들어 2022년 10월 개인맞춤의료연합(미국에 본부를 두고 과학자, 환자, 의료 서비스 프로바이더를 대표하며 환자와 의료 시스템에 혜택을 주는 개인맞춤의료에 대한 이해와 도입을 촉진하는 단체)의 추산에 따르면 복수 유형의 암, 유전적 희귀질환, 다양한 만성질환 및 감염증 환자를 대상으로 75,000개 이상의 유전자 검사 제품과 300개 이상의 맞춤형 의약품이 시장에 출시되고 있습니다. 따라서 맞춤형 의료에 대한 수요의 증가가 암 진단 시장의 성장을 지원하고 있습니다.

목차

제1장 주요 요약

• 암 진단 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 도표 리스트

제5장 리포트 구성

제6장 시장의 특징

• 일반적인 시장의 정의
• 개요
• 암 진단 시장 정의와 세분화
• 시장 세분화 : 방법별
  • 생검
  • 내시경검사
  • 종양 바이오마커 검사
  • 이미징
  • 기타 방법
• 시장 세분화 : 용도별
  • 자궁경부암
  • 유방암
  • 폐암
  • 뇌 및 중추신경계 암
  • 신장암
  • 대장암
  • 전립선암
  • 난소암
  • 위암
  • 기타 용도
• 시장 세분화 : 최종사용자별
  • 암연구기관
  • 진단 랩
  • 병원
  • 기타 최종사용자

제7장 암 진단 시장 : 거시경제 시나리오

• COVID-19의 영향 : 암 진단 시장
• 우크라이나 전쟁의 영향 : 암 진단 시장
• 고인플레이션의 영향 : 암 진단 시장

제8장 주요 시장 동향

• 자동 진단 솔루션을 제공하기 위한 기술의 진보
• 암 진단에서 혁신을 추진하는 전략적 제휴와 인수
• 암 탐지를 위한 혈액 순환 바이오마커의 개발
• 암 진단에서 AI 기반 툴에 주목

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 촉진요인 2018-2023
  • 시장 억제요인 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 촉진요인 2023-2028
  • 시장 억제요인 2023-2028

제10장 세계의 암 진단 시장 : 세분화

• 세계의 암 진단 시장 : 방법별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 암 진단 시장 : 용도별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 암 진단 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 암 진단 시장 : 지역·국가별 분석

• 세계의 암 진단 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 암 진단 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Thermo Fisher Scientific Inc.
• F. Hoffman-La Roche Ltd
• Abbott Laboratories
• Illumina Inc.
• Hologic Inc

제20장 경쟁 대시보드

제21장 주요 합병과 인수

• Quest Diagnostics Acquired Haystack Oncology Inc.
• Agilent Technologies Inc. Acquired Biomed Inc.
• Thermo Fisher Scientific Inc. Acquired The Binding Site Group
• Hologic Inc. Acquired Biotheranostics Inc.
• Illumina Inc. Acquired GRAIL

제22장 기회와 전략

• 2028년의 세계 암 진단 시장 : 새로운 기회를 제공하는 국가
• 2028년의 세계 암 진단 시장 : 새로운 기회를 제공하는 부문
• 2028년의 세계 암 진단 시장 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제23장 암 진단 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제24장 부록

영문목차

Cancer diagnosis refers to the process of identifying and determining the presence, type, extent and characteristics of cancer in a patient. This involves a variety of diagnostic techniques and tools aimed at detecting cancer, determining its stage and grade and guiding treatment decisions.

The cancer diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of cancer diagnostics technologies and methods that detect substances that may indicate the presence of cancer in the body.

The global cancer diagnostics market was valued at $16,778.81 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the cancer diagnostics market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Personalized medicine enhances cancer diagnostics by leveraging genomic profiling, targeted therapies, predictive biomarkers, precision imaging, clinical decision support and innovation in drug development. For instance, in October 2022, according to the Personalized Medicine Coalition's (US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system) estimates, more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Therefore, the increase in demand for personalized medicine supported the growth of the cancer diagnostics market.

Focus On AI-Based Tools In Cancer Diagnosis

Major companies in the cancer diagnostics market are focusing on developing AI-based tools by leveraging machine learning algorithms and big data analytics to improve accuracy, speed, and efficiency. For instance, in April 2023, Google Health, a UK-based platform that provides applications and technologies for healthcare and medical research, offering AI and machine vision technology for various health-related purposes, including skin condition and breast cancer research assistance, was actively involved in developing AI tools for cancer detection and diagnosis, leveraging machine learning algorithms to analyze medical images and improve diagnostic accuracy., Further, in July 2023, IBM, a US-based medical technology company, leveraged artificial intelligence (AI) to aid in cancer diagnostics by analyzing extensive data to offer insights for personalized treatment strategies. The use of AI in healthcare, particularly in cancer diagnosis, holds promise for enhancing patient care and treatment outcomes, but it also underscores the importance of thorough evaluation and refinement to ensure the accuracy and effectiveness of AI-driven tools in clinical settings.

The global cancer diagnostics market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up 13.16% of the total market in 2022.

Cancer Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cancer diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cancer diagnostics market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by method, by application and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cancer diagnostics market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by method, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Method: Biopsy, Endoscopy; Tumor Biomarker Tests; Imaging; Other Methods
• 2) By Application: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer; Other Applications
• 3) By End User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End-Users
• Companies Mentioned: Thermo Fisher Scientific Inc; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer diagnostics indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Cancer Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Cancer Diagnostics Market Definition And Segmentations
• 6.4 Market Segmentation By Method
  • 6.4.1 Biopsy
  • 6.4.2 Endoscopy
  • 6.4.3 Tumor Biomarker Tests
  • 6.4.4 Imaging
  • 6.4.5 Other Methods
• 6.5 Market Segmentation By Application
  • 6.5.1 Cervical Cancer
  • 6.5.2 Breast Cancer
  • 6.5.3 Lung Cancer
  • 6.5.4 Brain And Central Nervous System Cancer
  • 6.5.5 Kidney Cancer
  • 6.5.6 Colorectal Cancer
  • 6.5.7 Prostate Cancer
  • 6.5.8 Ovarian Cancer
  • 6.5.9 Stomach Cancer
  • 6.5.10 Other Applications
• 6.6 Market Segmentation By End-User
  • 6.6.1 Cancer Research Institutes
  • 6.6.2 Diagnostic Laboratories
  • 6.6.3 Hospitals
  • 6.6.4 Other End-Users

7 Cancer Diagnostics Market - Macro Economic Scenario

• 7.1 COVID-19 Impact On The Cancer Diagnostics Market
• 7.2 Impact Of The War In Ukraine On The Cancer Diagnostics Market
• 7.3 Impact Of High Inflation On The Cancer Diagnostics Market

8 Major Market Trends

• 8.1 Technological Advancements To Provide Automated Diagnostics Solutions
• 8.2 Strategic Partnerships And Acquisitions To Drive Innovation In Cancer Diagnostics
• 8.3 Developments In Blood-Borne Circulating Biomarkers For Cancer Detection
• 8.4 Focus On AI-Based Tools In Cancer Diagnosis

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Cancer Diagnostics Market Segmentation

• 10.1 Global Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Cancer Diagnostics Market, Regional and Country Analysis

• 11.1 Global Cancer Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Cancer Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.2 62
  • 12.1.3 62
  • 12.1.4 62
  • 12.1.5 Background Information
  • 12.1.6 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Cancer Diagnostics Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.1.13 Country Information
  • 12.1.14 Market Information
  • 12.1.15 Background Information
• 12.8 75
• 12.9 75
  • 12.9.1 75
  • 12.9.2 75
  • 12.9.3 75
  • 12.9.4 Government Initiatives
  • 12.1.16 Regulations
  • 12.1.17 Regulatory Bodies
  • 12.1.18 Major Associations
  • 12.1.19 Taxes Levied
  • 12.1.20 Corporate Tax Structure
  • 12.1.21 Investments
  • 12.1.22 Major Companies
• 12.1 China Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Cancer Diagnostics Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Cancer Diagnostics Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Cancer Diagnostics Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Cancer Diagnostics Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Thermo Fisher Scientific Inc.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial performance
• 19.3 F. Hoffman-La Roche Ltd
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Abbott Laboratories
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Illumina Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Hologic Inc
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Competitive Dashboard

21 Key Mergers And Acquisitions

• 21.1 Quest Diagnostics Acquired Haystack Oncology Inc.
• 21.2 Agilent Technologies Inc. Acquired Biomed Inc.
• 21.3 Thermo Fisher Scientific Inc. Acquired The Binding Site Group
• 21.4 Hologic Inc. Acquired Biotheranostics Inc.
• 21.5 Illumina Inc. Acquired GRAIL

22 Opportunities And Strategies

• 22.1 Global Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 22.2 Global Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 22.3 Global Cancer Diagnostics Market In 2028 - Growth Strategies
  • 22.3.1 Market Trend Based Strategies
  • 22.3.2 Competitor Strategies

23 Cancer Diagnostics Market, Conclusions And Recommendations

• 23.1 Conclusions
• 23.2 Recommendations
  • 23.2.1 Product
  • 23.2.2 Place
  • 23.2.3 Price
  • 23.2.4 Promotion
  • 23.2.5 People

24 Appendix

• 24.1 Geographies Covered
• 24.2 Market Data Sources
• 24.3 Research Methodology
• 24.4 Currencies
• 24.5 The Business Research Company
• 24.6 Copyright and Disclaimer